PATENT CLAIM ANALYSIS

Application Number: 15899539
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "646000"]

Abstract:
Aerosolized dapsone (or alternatively, an aqueous formulation of dapsone) is used to treat airway inflammation, particularly chronic neutrophil-dominated inflammation. Diseases that may be prevented or treated by the methods include chronic obstructive pulmonary diseases (COPDs), asthma, cystic fibrosis, and others.

Claim (Index 2):
The method of  claim 1 , wherein said formulation is an aerosolized formulation and said step of administering is carried out using a device selected from the group consisting of a metered-dose inhaler and a dry powder inhaler.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14970028', '14191219', '12574666', '14699620', '12972908']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7830236932275527
- 35 USC 102 Novelty (BERT): 0.5086662255640169
- Combined Prediction Score: 0.7555879464611992
- Mean Citation Score: 240.96068
- Max Citation Score: 243.88939
- Similarity Product: 159.87382587400498

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test